📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
WuXi Biologics (Cayman) Inc
WuXi Biologics (Cayman)'s GHG Emissions Data Preview
In 2024, WuXi Biologics (Cayman) completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
WuXi Biologics (Cayman) has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind WuXi Biologics (Cayman)’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore WuXi Biologics (Cayman)’s data sources below and access millions more through our Disclosure Search.
Insights into WuXi Biologics (Cayman)'s Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofWuXi Biologics (Cayman) amounted to198,654metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of WuXi Biologics (Cayman)increased by 9.2%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
WuXi Biologics (Cayman)'s Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are WuXi Biologics (Cayman)'s Scope 1 emissions?
In 2024, the total Scope 1 emissions of WuXi Biologics (Cayman) were 38,346 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has WuXi Biologics (Cayman) reduced its Scope 1 emissions over time?
Since 2019, WuXi Biologics (Cayman)'s Scope 1 emissions have increased by 262.3%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year(2023), WuXi Biologics (Cayman)'s Scope 1 emissions increased by 17.31%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
What are WuXi Biologics (Cayman)'s Scope 2 emissions?
In 2024, WuXi Biologics (Cayman) reported Scope 2 greenhouse gas (GHG) emissions of 158,207 tCOâ‚‚e using the market-based method and 160,308 tCOâ‚‚e using the location-based method.a
Has WuXi Biologics (Cayman) reduced its Scope 2 emissions over time?
Compared to the previous year(2023), WuXi Biologics (Cayman)'s Scope 2 emissions(Location-Based) have remained relatively stable, indicating that WuXi Biologics (Cayman)'s emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does WuXi Biologics (Cayman) use for Scope 2 reporting?
In 2024, WuXi Biologics (Cayman) reported its Scope 2 emissions using the market-based method and using the location-based method.a
WuXi Biologics (Cayman)'s Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into WuXi Biologics (Cayman)'s Value Chain Emissions
In 2024, WuXi Biologics (Cayman) reported 71,244 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of WuXi Biologics (Cayman) includes a breakdown across 6of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
WuXi Biologics (Cayman)'s Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are WuXi Biologics (Cayman)'s Scope 3 emissions?
In 2024, WuXi Biologics (Cayman) reported total Scope 3 emissions of 71,244 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 100%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0%came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), WuXi Biologics (Cayman)'s Scope 3 emissions remained relatively stable, indicating that WuXi Biologics (Cayman)'s emissions have plateaued with no significant change in its value chain footprint.a
What categories of Scope 3 emissions does WuXi Biologics (Cayman) disclose?
In 2024, WuXi Biologics (Cayman) reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of WuXi Biologics (Cayman)'s Scope 3 emissions?
In 2024, the largest contributors to WuXi Biologics (Cayman)'s Scope 3 emissions were:a
- Fuel- and Energy-Related Services (Cat. 3): 39,468 tCOâ‚‚e(55.4%)
- Employee Commuting (Cat. 7): 19,176 tCOâ‚‚e(26.92%)
- Waste Generated in Operations (Cat. 5): 5,868 tCOâ‚‚e(8.24%)
WuXi Biologics (Cayman)'s Scope 3 Emissions by Categories
Insights into WuXi Biologics (Cayman)’s GHG Emissions Intensity Compared to Industry Peers
In 2024, WuXi Biologics (Cayman) reported Scope 1 greenhouse gas (GHG) emissions of 38,346 tCOâ‚‚e and total revenues of USD 2,779 millions. This translates into an emissions intensity of 13.8 tCOâ‚‚e per millions USD.a
WuXi Biologics (Cayman)'s Scope 1 Emissions Intensity Compared to Peers
How does WuXi Biologics (Cayman)'s GHG emissions intensity compare to its peers?
In 2024, WuXi Biologics (Cayman) reported a Scope 1 emissions intensity of 13.8 tCOâ‚‚e per millions USD. Compared to the peer group median of 8.41, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does WuXi Biologics (Cayman) rank on GHG emissions intensity within its industry?
In 2024, WuXi Biologics (Cayman) ranked 16 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
WuXi Biologics (Cayman) is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
Insights into WuXi Biologics (Cayman)'s Total Carbon Footprint
In 2024, WuXi Biologics (Cayman) reported a total carbon footprint of 269,898 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 9.1% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to WuXi Biologics (Cayman)'s total carbon footprint was Scope 2 emissions, accounting for 59.4% of the company's total carbon footprint, followed by Scope 3 emissions at 26.4%.a